Cargando…

PMN‐MDSCs‐induced accumulation of CD8+CD39+ T cells predicts the efficacy of chemotherapy in esophageal squamous cell carcinoma

Detalles Bibliográficos
Autores principales:	Qin, Guohui, Liu, Jinyan, Lian, Jingyao, Zhang, Huanyu, Lei, Qingyang, Yang, Huiyun, Shao, Jingwen, Chen, Xinfeng, Zhang, Bin, Zhang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654625/ https://www.ncbi.nlm.nih.gov/pubmed/33252852 http://dx.doi.org/10.1002/ctm2.232

Ejemplares similares

Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs
por: Mastio, Jérôme, et al.
Publicado: (2019)

TRAIL promotes epithelial-to-mesenchymal transition by inducing PD-L1 expression in esophageal squamous cell carcinomas
por: Zhang, Huanyu, et al.
Publicado: (2021)

Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice
por: Kawano, Tomohiro, et al.
Publicado: (2019)

mTOR Signaling Regulates the Development and Therapeutic Efficacy of PMN-MDSCs in Acute GVHD
por: Li, Xiaoqing, et al.
Publicado: (2021)

MDSCs-derived GPR84 induces CD8(+) T-cell senescence via p53 activation to suppress the antitumor response
por: Liu, Jinyan, et al.
Publicado: (2023)

Short-chain fatty acids ameliorate allergic airway inflammation via sequential induction of PMN-MDSCs and Treg cells
por: Huang, Min-Ting, et al.
Publicado: (2023)

PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway
por: Zhang, Rui, et al.
Publicado: (2023)

CD39-Expressing CD8(+) T Cells as a New Molecular Marker for Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma
por: Liu, Meitong, et al.
Publicado: (2023)

ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer
por: Chen, Huanhuan, et al.
Publicado: (2023)

WASH overexpression enhances cancer stem cell properties and correlates with poor prognosis of esophageal carcinoma
por: Huang, Lan, et al.
Publicado: (2017)

PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling
por: Sprouse, Marc L., et al.
Publicado: (2019)

Cancer-educated mesenchymal stem cells promote the survival of cancer cells at primary and distant metastatic sites via the expansion of bone marrow-derived-PMN-MDSCs
por: Sai, Buqing, et al.
Publicado: (2019)

Elevated frequencies of CD14(+)HLA-DR(lo/neg) MDSCs in COVID-19 patients
por: Xue, GuoHui, et al.
Publicado: (2021)

Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma
por: Qin, Guohui, et al.
Publicado: (2017)

Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion
por: Li, Xing, et al.
Publicado: (2021)

Monocytic MDSCs homing to thymus contribute to age-related CD8(+) T cell tolerance of HBV
por: Fang, Zhong, et al.
Publicado: (2022)

Accumulation of LOX-1(+) PMN-MDSCs in nasopharyngeal carcinoma survivors with chronic hepatitis B might permit immune tolerance to epstein–barr virus and relate to tumor recurrence
por: Li, Xing, et al.
Publicado: (2020)

In contrast to CD64 expression, CD14 expression is persistently downregulated on polymorphonuclear cells (PMN) but not on monocytes of patients with septic shock
por: Barth, E, et al.
Publicado: (2000)

Local production of the chemokines CCL5 and CXCL10 attracts CD8(+) T lymphocytes into esophageal squamous cell carcinoma
por: Liu, Jinyan, et al.
Publicado: (2015)

CD39 Regulation and Functions in T Cells
por: Timperi, Eleonora, et al.
Publicado: (2021)

CD39(+) regulatory T cells accumulate in colon adenocarcinomas and display markers of increased suppressive function
por: Ahlmanner, Filip, et al.
Publicado: (2018)

CD39 Expression Identifies Terminally Exhausted CD8(+) T Cells
por: Gupta, Prakash K., et al.
Publicado: (2015)

NK Cells and PMN-MDSCs in the Graft From G-CSF Mobilized Haploidentical Donors Display Distinct Gene Expression Profiles From Those of the Non-Mobilized Counterpart
por: Pelosi, Andrea, et al.
Publicado: (2021)

Connecting METTL3 and intratumoural CD33(+) MDSCs in predicting clinical outcome in cervical cancer
por: Ni, Huan-he, et al.
Publicado: (2020)

CD39: the potential target in small cell lung cancer
por: Chen, Shanhao, et al.
Publicado: (2020)

The ectonucleotidases CD39 and CD73 on T cells: The new pillar of hematological malignancy
por: Jiang, Xuan, et al.
Publicado: (2023)

Persistent T cell proliferation and MDSCs expansion precede incomplete CD4(+) T cell recovery in people with acute HIV-1 infection with early ART
por: Li, Zhen, et al.
Publicado: (2023)

Correlation of PMN elastase and PMN elastase-to-neutrophil ratio with disease activity in patients with myositis
por: Wu, Siyu, et al.
Publicado: (2019)

CD38(+)CD39(+) NK cells associate with HIV disease progression and negatively regulate T cell proliferation
por: Qian, Shi, et al.
Publicado: (2022)

Characterization of the Effects of Cross-Linking of Macrophage CD44 Associated with Increased Phagocytosis of Apoptotic PMN
por: Hart, Simon P., et al.
Publicado: (2012)

NEDD9 promotes cancer stemness by recruiting myeloid-derived suppressor cells via CXCL8 in esophageal squamous cell carcinoma
por: Yue, Dongli, et al.
Publicado: (2021)

Interleukin‐33‐nuclear factor‐κB‐CCL2 signaling pathway promotes progression of esophageal squamous cell carcinoma by directing regulatory T cells
por: Yue, Ying, et al.
Publicado: (2020)

CD8+CD39+ T Cells Mediate Anti-Tumor Cytotoxicity in Bladder Cancer
por: Zhu, Wenjie, et al.
Publicado: (2021)

Point mutation in CD19 facilitates immune escape of B cell lymphoma from CAR-T cell therapy
por: Zhang, Zhen, et al.
Publicado: (2020)

Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
por: Schäkel, Laura, et al.
Publicado: (2020)

Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
por: Shevchenko, Ivan, et al.
Publicado: (2020)

CD39(+)PD-1(+)CD8(+) T cells mediate metastatic dormancy in breast cancer
por: Tallón de Lara, Paulino, et al.
Publicado: (2021)

Chemoradiotherapy-Induced CD4(+) and CD8(+) T-Cell Alterations to Predict Patient Outcomes in Esophageal Squamous Cell Carcinoma
por: Chen, Xi, et al.
Publicado: (2019)

Low Pretreatment CD4(+):CD8(+) T Cell Ratios and CD39(+)CD73(+)CD19(+) B Cell Proportions Are Associated with Improved Relapse-Free Survival in Head and Neck Squamous Cell Carcinoma
por: Turner, Ross J., et al.
Publicado: (2023)

Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4(+) CD25(high)Foxp3(+) regulatory T‐cells in psoriasis
por: Han, Ling, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9q7lsahus6ottp31crivt2n6os